Adaptive Biotech Gets $195M to Dig Deep Into The Immune System's Secrets

Adaptive Biotechnologies is helping scientists look at the immune system in a new way, with a combination of DNA sequencing and high-powered computation. Now the small private company just got $195 million from some familiar Wall Street investors to see if its technology platform can really shake up the way we think about infectious diseases, autoimmunity, and cancer.